The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone
Open accessAbstract
The mass of regenerating tissues, such as bone, is critically dependent on the number of executive cells, which in turn is determined by the rate of replication of progenitors and the life-span of mature cells, reflecting the timing of death by apoptosis. Bone mass can be increased by intermittent parathyroid hormone (PTH) administration, but the mechanism of this phenomenon has remained unknown. We report that daily PTH injections in mice with either normal bone mass or osteopenia due to defective osteoblastogenesis increased bone formation without affecting the generation of new osteoblasts. Instead, PTH increased the life-span of mature osteoblasts by preventing their apoptosis - the fate of the majority of these cells under normal conditions. The antiapoptotic effect of PTH was sufficient to account for the increase in bone mass, and was confirmed in vitro using rodent and human osteoblasts and osteocytes. This evidence provides proof of the basic principle that the work performed by a cell population can be increased by suppression of apoptosis. Moreover, it suggests novel pharmacotherapeutic strategies for osteoporosis and, perhaps, other pathologic conditions in which tissue mass diminution has compromised functional integrity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thornberry, N. A., & Lazebnik, Y. (1998) · Science · doi:10.1126/science.281.5381.1312 · Cited by 6,887
Parfitt, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. A., Malluche, H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020617 · Cited by 5,016
Self-citationBone Histomorphometry : Standardization of Nomenclature, Symbols, and Units
PARFITT, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. А., Malluche, H. H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · Cited by 3,258
Self-citationThe Fire of Life: An Introduction to Animal Energetics
Kleiber, M. (1975) · Medical Entomology and Zoology · Cited by 2,529
A short amino acid sequence able to specify nuclear location
Kalderon, D., Roberts, B. L., Richardson, W. D., & Smith, A. E. (1984) · Cell · doi:10.1016/0092-8674(84)90457-4 · Cited by 2,507
Weinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2799 · Cited by 1,753 · cited 9×
“Although this dose is relatively high, our findings are consistent with previous evidence that the anabolic effect of 400 ng/g/d hPTH(1-34) in rats occurred without an increase in bone resorption (9).”
BackgroundMethodResultInfluentialSelf-citationManolagas, S. C., & Jilka, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320506 · Cited by 1,668
Self-citationIncreased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6
Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B., Broxmeyer, H., & Manolagas, S. C. (1992) · Science · doi:10.1126/science.1621100 · Cited by 1,442
Self-citationThree rules for bone adaptation to mechanical stimuli
Turner, C. H. (1998) · Bone · doi:10.1016/s8756-3282(98)00118-5 · Cited by 969
Anabolic Actions of Parathyroid Hormone on Bone*
DEMPSTER, D. W., COSMAN, F., PARISIEN, M., SHEN, V., & LINDSAY, R. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-6-690 · Cited by 717
Hsu, S. M., & Soban, E. (1982) · Journal of Histochemistry & Cytochemistry · doi:10.1177/30.10.6182185 · Cited by 659
Dobnig, H. (1995) · Endocrinology · doi:10.1210/en.136.8.3632 · Cited by 615
TAM, C. S., HEERSCHE, J. N. M., MURRAY, T. M., & PARSONS, J. A. (1982) · Endocrinology · doi:10.1210/endo-110-2-506 · Cited by 612
Reeve, J., Meunier, P. J., Parsons, J. A., Bernat, M., Bijvoet, O. L., Courpron, P., Edouard, C., Klenerman, L., Neer, R. M., Renier, J. C., et al. (1980) · BMJ · doi:10.1136/bmj.280.6228.1340 · Cited by 582
Osteoblast Programmed Cell Death (Apoptosis): Modulation by Growth Factors and Cytokines
Jilka, R. L., Weinstein, R. S., Bellido, T., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.5.793 · Cited by 578 · cited 9×
“Murine osteoblastic MC3T3-E1 cells and human osteoblastic MG-63 cells were cultured as previously described (15).”
BackgroundMethodResultInfluentialSelf-citationLane, N. E., Sanchez, S., Modin, G. W., Genant, H. K., Pierini, E., & Arnaud, C. D. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3914 · Cited by 529
Establishment of an osteocyte-like cell line, MLO-Y4
Kato, Y., Windle, J. J., Koop, B. A., Mundy, G. R., & Bonewald, L. F. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.12.2014 · Cited by 500
Bursch, W., Paffe, S., Putz, B., Barthel, G., & Schulte-Hermann, R. (1990) · Carcinogenesis · doi:10.1093/carcin/11.5.847 · Cited by 444
Function of osteocytes in bone
Aarden, E. M., Nijweide, P. J., & Burger, E. H. (1994) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240550304 · Cited by 409
Aubin, J. E. (1998) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(1998)72:30/31+<73::aid-jcb11>3.0.co;2-l · Cited by 390
Jilka, R. L., Weinstein, R. S., Takahashi, K., Parfitt, A. M., & Manolagas, S. C. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118600 · Cited by 339
Self-citationAmling, M., Neff, L., Tanaka, S., Inoue, D., Kuida, K., Weir, E., Philbrick, W. M., Broadus, A. E., & Baron, R. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.136.1.205 · Cited by 304
The Role of Estrogen in the Control of Rat Osteocyte Apoptosis
Tomkinson, A., Gevers, E. F., Wit, J. M., Reeve, J., & Noble, B. S. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.8.1243 · Cited by 302
Lee, K. (1996) · Endocrinology · doi:10.1210/en.137.11.5109 · Cited by 288
Nishida, S., Yamaguchi, A., Tanizawa, T., Endo, N., Mashiba, T., Uchiyama, Y., Suda, T., Yoshiki, S., & Takahashi, H. E. (1994) · Bone · doi:10.1016/8756-3282(94)90322-0 · Cited by 253
Jilka, R. L., Takahashi, K., Munshi, M., Williams, D. C., Roberson, P. K., & Manolagas, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1039 · Cited by 212
Self-citationFinkelstein, J. S., Klibanski, A., Arnold, A. L., Toth, T. L., Hornstein, M. D., & Neer, R. M. (1998) · JAMA · doi:10.1001/jama.280.12.1067 · Cited by 166
Weinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1997) · Endocrinology · doi:10.1210/endo.138.9.5359 · Cited by 126
Self-citationLeaffer, D., Sweeney, M., Kellerman, L., et al. (1995) · Endocrinology · doi:10.1210/endo.136.8.7628402 · Cited by 116
Dempster, D. W. (1993) · Endocrine Reviews · doi:10.1210/er.14.6.690 · Cited by 90
Wright, S. C., Schellenberger, U., Wang, H., Kinder, D. H., Talhouk, J. W., & Larrick, J. W. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.7.1107 · Cited by 89
Perry, S. W., Epstein, L. G., & Gelbard, H. A. (1997) · BioTechniques · doi:10.2144/97226st01 · Cited by 70
Bone-selective analogs of human PTH(1–34) increase bone formation in an ovariectomized rat model
Lane, N. E., Kimmel, D. B., NILSSON, M. H. L., et al. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110509 · Cited by 66
Onishi, T., Zhang, W., Cao, X., & Hruska, K. A. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.10.1596 · Cited by 58
Sphingosine Kinase Mediates Cyclic AMP Suppression of Apoptosis in Rat Periosteal Cells
Machwate, M., Rodan, S. B., Rodan, G. A., & Harada, S.-I. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.1.70 · Cited by 54
VICKERY, B. H., Avnur, Z., Cheng, Y., Chiou, S., Leaffer, D., CAULFIELD, J. P., Ho, T., Krstenansky, J. L., & Kimmel, D. B. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650111216 · Cited by 48
Jilka, R. L. (1986) · Bone · doi:10.1016/8756-3282(86)90149-3 · Cited by 36
Self-citationA New Method for Identification of Cement Lines in Undecalcified, Plastic Embedded Sections of Bone
Villanueva, A. R., Sypitkowski, C., & PARFITT, A. M. (1986) · Stain Technology · doi:10.3109/10520298609110713 · Cited by 32
Self-citationSilvestrini, G., Mocetti, P., Ballanti, P., Grezia, R. D., & BONUCCI, E. (1998) · Tissue and Cell · doi:10.1016/s0040-8166(98)80081-5 · Cited by 28
Pompeiano, M., Hvala, M., & Chun, J. J. M. (1998) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400403 · Cited by 22
Cited by
Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,568
Self-citationTherapeutic Approaches to Bone Diseases
Rodan, G. A., & Martin, T. J. (2000) · Science · doi:10.1126/science.289.5484.1508 · Cited by 1,767
Glucocorticoid-induced osteoporosis: pathophysiology and therapy
Canalis, E., Mazziotti, G., Giustina, A., & Bilezikian, J. P. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0394-0 · Cited by 1,114
Nongenotropic, Sex-Nonspecific Signaling through the Estrogen or Androgen Receptors
Kousteni, S., Bellido, T., Plotkin, L. I., O'Brien, C. A., Bodenner, D. L., Han, L., Han, K., DiGregorio, G. B., Katzenellenbogen, J. A., Katzenellenbogen, B. S., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00268-9 · Cited by 1,113
Self-citationTeriparatide or Alendronate in Glucocorticoid-Induced Osteoporosis
Saag, K. G., Shane, E., Boonen, S., Marín, F., Donley, D. W., Taylor, K. A., Dalsky, G. P., & Marcus, R. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071408 · Cited by 914
Metadata
- Authors
- Jilka, R. L., Weinstein, R. S., Bellido, T., Roberson, P., Parfitt, A. M., & Manolagas, S. C.
- Venue
- Journal of Clinical Investigation
- Published
- 1999-08-15
- Volume
- 104
- Issue
- 4
- Pages
- 439-446
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2143214738
- Cited by
- 1,043
- References
- 40
- FWCI
- 13.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.